Peter Mazzone, MD, MPH

Appointed
2001

Education & Fellowships

Graduate School - Northeastern Ohio Univ College of Medicine
MPH
Rootstown, OH USA
2001

Fellowship - Cleveland Clinic
Pulmonary & Critical Care Medicine
Cleveland, OH USA
2001

Residency - Cleveland Clinic
Internal Medicine
Cleveland, OH USA
1998

Internship - Cleveland Clinic
Internal Medicine
Cleveland, OH USA
1995

Medical Education - University of Western Ontario Schulich School of Medicine & Dentistry
MD
London, ON Canada
1994

Undergraduate - University of Western Ontario
London, Ontario,
1990

Professional Highlights

• Former Chair, Thoracic Oncology Network of the American College of Chest Physicians.
• Chair, Planning Committee, Thoracic Oncology Assembly of the American Thoracic Society.
• Cancer Biomarkers Study Section, NIH.
• Member of Executive Committee Lung Cancer Living Guidelines for the American College of Chest Physicians. Lead of Lung Cancer Screening Guideline.
• Member of Committees for Implementation of Lung Cancer Screening, American College of Chest Physicians and American Thoracic Society.
• American Lung Association - National Lung Cancer Expert Medical Advisory Panel.
• Chest 2016 - Program Vice-Chair, Chest 2017 - Program Chair
• American Cancer Society Lung Cancer Screening Roundtable

Certifications

• Internal Medicine
• Internal Medicine - Pulmonary Disease
• Internal Medicine - Critical Care Medicine

Specialty Interests

Acute respiratory distress syndrome(ARDS), lung cancer, lung nodules, sepsis Acute respiratory distress syndrome(ARDS), asthma, lung cancer, lung nodules, lung cancer screening, pneumonia, sepsis

Awards & Honors

• Best Doctors in America, 2004-2016
• Guide to America's Top Physicians, 2004-2016
• Cleveland's Best Doctors, 2006-2016
• Best Doctors, Northern Ohio Live magazine, 2007-2008

Innovations & Patents

• The development of a breath test (volatile metabolites) for the identification of lung cancer (research in progress).
• The development of a urine test (volatile metabolites) for the identification of lung cancer (research in progress).
• The development of a blood test (non-volatile small molecule metabolites) for the identification of lung cancer (research in progress).

Memberships

• American Thoracic Society
• American College of Chest Physicians
• International Association for the Study of Lung Cancer

See publications for Peter Mazzone, MD, MPH.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 6/22/2023, Dr. Mazzone has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.